Praxis Precision Medicine...

NASDAQ: PRAX · Real-Time Price · USD
47.14
-0.56 (-1.17%)
At close: Aug 15, 2025, 3:59 PM
47.08
-0.13%
After-hours: Aug 15, 2025, 04:10 PM EDT

Praxis Precision Medicines Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 7.46M 302K 357K 431K 515K 468K 781K 683K n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
46K n/a 47K n/a 107K 112K 111K 321K 312K 307K 301K 292K 305K 273K 563K 506K 319K 206K
Gross Profit
-46K n/a 7.42M 302K 250K 319K 404K 147K 469K 376K -301K -292K -305K -273K -563K -506K -319K -206K
Operating Income
-76.07M -74.73M -63.96M -56.84M -37.49M -41.89M -27.81M -25.52M -34.96M -38.09M -41.45M -44.29M -60.39M -68.85M -58.66M -44.77M -36.48M -27.42M
Interest Income
4.94M n/a n/a n/a n/a n/a 928K 884K 648K n/a n/a n/a 200K n/a n/a n/a n/a 46K
Pretax Income
-71.13M -69.3M -58.68M -51.91M -32.68M -39.55M -26.88M -24.63M -34.31M -37.45M -41.17M -43.95M -60.19M -68.72M -58.59M -44.7M -36.4M -27.37M
Net Income
-71.13M -69.3M -58.68M -51.91M -32.68M -39.55M -26.88M -24.63M -34.31M -36.82M -40.89M -43.6M -59.99M -68.58M -58.58M -44.7M -36.4M -27.37M
Selling & General & Admin
13.02M 13.92M 15.13M 15.26M 10.59M 15.33M 9.93M 8.72M 10.13M 13.27M 13.12M 13.85M 16.77M 16.2M 15.15M 11.63M 10.8M 9.49M
Research & Development
63.01M 60.81M 56.29M 41.88M 27.26M 26.98M 18.39M 17.26M 25.61M 25.5M 28.33M 30.44M 43.62M 52.65M 43.51M 33.14M 25.68M 17.93M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a 884K n/a n/a 280K 345K 200K 132K 70K 73K 82K n/a
Operating Expenses
76.02M 74.73M 71.42M 57.14M 37.84M 42.32M 28.32M 25.98M 35.74M 38.77M 41.45M 44.29M 60.39M 68.85M 58.66M 44.77M 36.48M 27.42M
Interest Expense
n/a n/a n/a n/a n/a n/a 106K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
76.07M 74.73M 71.42M 57.14M 37.84M 42.32M 28.32M 25.98M 35.74M 38.77M 41.45M 44.29M 60.39M 68.85M 58.66M 44.77M 36.48M 27.42M
Income Tax Expense
n/a n/a n/a n/a -107K -112K n/a -109K -16.09K -636K -280K -345K -200K -132K -5K 5K -292K -183K
Shares Outstanding (Basic)
21.47M 21.06M 19.98M 18.88M 18.82M 13.9M 9.06M 9.04M 4.65M 3.54M 3.17M 3.05M 3.04M 3.03M 3M 2.98M 2.77M 2.56M
Shares Outstanding (Diluted)
21.47M 21.06M 19.98M 18.88M 18.82M 13.9M 9.06M 9.04M 4.65M 3.54M 3.17M 3.05M 3.04M 3.03M 3M 2.98M 2.77M 2.56M
EPS (Basic)
-3.31 -3.29 -2.94 -2.75 -1.74 -2.84 -2.97 -2.72 -7.38 -10.4 -12.89 -14.29 -19.76 -22.63 -19.54 -15 -13.13 -10.67
EPS (Diluted)
-3.31 -3.29 -2.94 -2.75 -1.74 -2.84 -2.97 -2.72 -7.38 -10.4 -12.89 -14.29 -19.76 -22.63 -19.54 -15 -13.13 -10.67
EBITDA
-71.08M -74.68M -63.91M -56.74M -37.38M -41.77M -27.7M -25.41M -34.85M -37.98M -41.35M -44.19M -60.39M -68.76M -58.56M -44.73M -36.46M -27.4M
EBIT
-71.13M -74.73M -63.96M -56.84M -37.49M -41.89M -27.81M -25.52M -34.96M -38.09M -41.45M -44.29M -60.39M -68.85M -58.66M -44.77M -36.48M -27.42M
Depreciation & Amortization
46K 47K 47K 92K 107K 112K 111K 321K 312K 307K 301K 292K 305K 273K 563K 506K 319K 206K